Publications by authors named "Ahmed Elwaleed"
Article Synopsis
- Artisanal and small-scale gold mining (ASGM) in Sudan poses serious health risks due to high mercury emissions, particularly in the Abu Hamad community.
- Analysis of soil and water samples showed peak mercury levels near amalgam burning sites, with significant health hazards identified for both adults and children who live close to these areas.
- The study highlights the critical need for safer mining practices, such as using retorts, to minimize mercury exposure and safeguard the health of ASGM communities.
Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole.
Case Rep Infect Dis
August 2018
Article Synopsis
- Infections in solid-organ transplant recipients are uncommon but can lead to high mortality rates.
- A case study is presented involving a kidney transplant recipient who contracted an infection.
- The patient was treated with oral voriconazole for five months and showed a positive response to the treatment.
Epilepsy is commonly encountered in children with attention deficit hyperactivity disorder (ADHD). This study aims to determine the spectrum of ADHD among Sudanese children with epilepsy. The study was conducted at the Epilepsy and Neurodisabilities Outpatient Clinic for Children at Saad Abu Elila University Hospital, Khartoum, Sudan during the period January - July 2013.
View Article and Find Full Text PDFThe amino terminal region of group A streptococcal M proteins evokes type-specific immunity while the conserved C-repeat epitopes evoke cross-protective immunity against multiple serotypes. The present studies were undertaken to compare the protective efficacy of vaccines containing either type-specific (hexavalent vaccine) or conserved C-repeat (J14 vaccine) M protein epitopes and to determine if combination vaccines resulted in enhanced levels of protection. Our results indicated that the protective efficacy of the type-specific vaccine was significantly greater than that of J14 and that the addition of J14 to vaccine formulations did not enhance the level of protection achieved with type-specific formulations.
View Article and Find Full Text PDF